7 European VCs Investing in MedTech
The European medtech sector was valued at approximately €170 billion in 2024, as reported by MedTech Europe. The leading markets in Europe include Germany, France, the UK, Italy, and Spain, collectively accounting for 26.4% of the global medtech market, closely following the United States.
Definition of MedTech
Medtech, or medical technology, refers to devices and software designed for diagnosing, treating, and managing ongoing health conditions. This includes a broad spectrum of technologies such as hearing devices, scanners, treatments, robotics, and AI-based diagnostics. Medtech focuses on curing diseases using technology, as opposed to healthtech, which encompasses preventative treatments.
Investment Entities in MedTech
MTIP
MTIP is a European healthcare software investor focusing on high-growth, profitable healthcare software companies, including those within the medtech sector. They prioritize SaaS B2B companies with recurring revenue models. Their portfolio includes startups such as Koa Health, Intelligencia AI, Mediktor, and Apricity.
Panakès
Panakès is a venture capital fund investing in life sciences companies aimed at enhancing global quality of life. They support early-stage startups and SMEs across Europe and Israel, offering both financial backing and expertise in medical sciences. Their portfolio includes innovative medtech companies across various domains.
Verve Ventures
Verve Ventures is a European deep-tech venture capital investor. They have invested in over 150 science and tech startups across Europe, focusing on innovations in energy, computing, and health sectors.
Sofinnova Partners
Sofinnova Partners specializes in life science investments, covering both seed and later-stage ventures. The fund concentrates on healthcare and sustainability, acting as a founding investor in early-stage biopharma and medtech startups developing new therapeutic technologies. Additionally, they have an in-house medtech accelerator to support strategic growth.
NLC
NLC operates several funds to support various sectors. The NLC Health Impact Fund is their latest and largest, focusing on investments in Europe and the US, aiming to allocate €33.4M into over 60 health impact companies.
Nina Capital
Nina Capital is a venture capital firm investing at the intersection of healthcare and technology, focusing on companies in Europe, the US, Israel, Canada, and Australia. They provide funding ranging from €200k to €1.5M.
SHS Capital
SHS Capital invests in fast-growing companies aspiring to become European healthcare leaders. With over 70 investments to date and ticket sizes exceeding €10M, they provide access to an extensive network built over 30 years in the sector, supporting companies shaping the future of European healthcare.